The game-changing weight loss jabs have ushered in a new era in the war on obesity, but have also been linked to other health ...

A new study suggests that the anti-obesity drug tirzepatide may help reduce the growth of breast cancer linked to obesity.

The team found that the tirzepatide-treated mice lost about 20 percent of their body weight, mostly from reduced fat mass. In tandem, their breast tumors shrank, with researchers noting that tumor ...

The trial findings indicated that once-monthly maridebart cafraglutide caused a 12.3% to 16.2% reduction in mean body weight among participants with obesity following 52 weeks of treatment.

The study, conducted in mice, links diet-induced obesity with anxiety-like symptoms, alterations in brain signaling and differences in gut microbes that may contribute to impaired brain functioning.

Teenagers should be offered a “transformative” anti-obesity treatment to help them lose weight, experts have said. Academics said that the weight loss injection semaglutide could help ...

Blocking a protein called CD44 has been shown to protect against obesity in mice on a high-fat diet, specifically by suppressing the formation of white fat cells.

Trans-omic analysis reveals opposite metabolic dysregulation between feeding and fasting in liver associated with obesity. iScience, 2024; 109121 DOI: 10.1016/j.isci.2024.109121 ...

Like Ozempic, whose name is now a catchall term for obesity drugs, Wegovy and Zepbound come packaged in Sharpie-like injection pens that patients self-administer once a week.